Le Lézard
Classified in: Health
Subjects: SVY, WOM

Sanitary Napkin for Feminine Care Market is Projected to Reach US$ 40 Bn by 2025 - QYResearch.com


LOS ANGELES, TOKYO and PUNE, India, July 23, 2018 /PRNewswire/ --

The Sanitary Napkin for Feminine Care industry was 20,968 million USD in 2017 and is projected to reach 39,613 million USD by 2025, at a CAGR (Compounded Annual Growth Rate) of 8.28% between 2017 and 2025. The market is driven by various end-user industries, such as Supermarket, Convenience Store, Online Sales and others.

     (Logo: https://mma.prnewswire.com/media/719476/QY_Research_Logo.jpg )

The industry is concentration, the key brand include Procter & Gamble, Kimberly-Clark, Unicharm, Hengan, Johnson & Johnson, Essity, Kingdom Healthcare, Kao Corporation, Jieling, Edgewell Personal Care Company, Elleair, KleanNara, Ontex International, Corman SpA, Bjbest are the leaders.

Report Overview@ https://www.qyresearch.com/index/detail/581413/global-sanitary-napkin-for-feminine-care-sales-market

The leading companies own the advantages on better performance, more abundant product's types, better technical and impeccable after-sales service. Consequently, they take the majority of the market share of high-end market. Looking to the future years, the slow downward price trend in recent years will maintain. As competition intensifies, prices gap between different brands will go narrowing. Similarly, there will be fluctuation in gross margin.

The industry is expected to remain innovation-led, with frequent acquisitions and strategic alliances adopted as the key strategies by the players to increase their industry presence. Market stays in mature period with a clear concentration. Meanwhile, optimize product mix and further develop value-added capabilities to maximize margins.

In the last several years, global market of Sanitary Napkin for Feminine Care developed rapidly, with an average growth rate of 7.61% during 2013 to 2017. In 2017, global revenue of Sanitary Napkin for Feminine Care is nearly 20.97 Billion USD; the actual sales are about 256303 M Unit.

The classification of sanitary napkin for feminine care includes daily use and night use, and the proportion of sanitary napkin for feminine care for daily use in 2017 is about 69%.

Sanitary Napkin for Feminine Care is widely purchased in supermarket, convenience store, online sales and others. The most proportion of Sanitary Napkin for Feminine Care is purchased in supermarket, and the proportion in 2017 is about 58.7%.

Request Sample Report@ https://www.qyresearch.com/sample-form/form/581413/global-sanitary-napkin-for-feminine-care-sales-market

On the basis of product, this report displays the production, revenue, price, and market share and growth rate of each type, primarily split into

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

The Global Sanitary Napkin for Feminine Care Market Research Report 2018 report released by QYResearch provides a basic overview of the Sanitary Napkin for Feminine Care industry, including definition, classification, application and industrial chain structure. Discuss development policies and plans as well as manufacturing processes and cost structures.

Request to buy Full Report@ https://www.qyresearch.com/request-discount/form/581413/global-sanitary-napkin-for-feminine-care-sales-market

The report then focuses on major industry players in Global, including company profiles, product images and specifications, sales, market share, and contact information. More importantly, the Sanitary Napkin for Feminine Care industry development trends and marketing channels were analysed. Providing the main statistical data on the current status of the industry is a valuable guide and direction for companies and individuals interested in the market.

More Consumer Good related Reports@ https://www.qyresearch.com/index/list/58/consumer-goods

About Us:  

QY Research, Established in 2007: focuses on custom research, management consulting, IPO consulting, industry chain research, and data base &seminar services. QY Research has more than 34000 global well-known customers, covering more than 30 industries including energy, automobiles, pharmaceuticals, chemicals, agriculture, etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world. QYResearch built research or marketing centres in China (Beijing, Shanghai, Guangzhou, and Hong Kong), USA, Canada, Germany, UK, France, etc.

Currently, QYResearch has become the first choice, worthy and trusted consulting brand in Global and China business consulting services.

QY Research Achievements: 

Year of Experience: 11 Years

Consulting Projects: 500+ successfully conducted so far

Global Reports: 5000 Reports Every Years

Resellers Partners for Our Reports: 150 + Across Globe

Global Clients: 34000+

Contact US:
USA Registered Office:
QY Research, INC.  
17890 Castleton, Suite 218,
City of industry, CA - 91748   
USA: +1-6262-952-442

Japan Registered Office:
Ginza wall building 5F, 6-13-16,
Ginza, Chuo-ku, Tokyo, 104-0061, Japan
Tel.: +81-9038009273; +81-345704342

India Registered Office:
102, Siddh Icon,
Opposite Royal Enfield Showroom,
Baner Road, Baner, Pune - 411045,
Maharashtra, India
Tel: +91-9766-478-224
Emails - [email protected]
[email protected]

Media:
Rahul Singh
Director - Digital Marketing
Mob. +91-7028920828

Sales:
Hitesh Balchandani
Director Sales
Mob. +91-9766478224

Web - http://www.qyresearch.com 
Expert News: https://www.qyresearch.com/expert/list



These press releases may also interest you

at 02:15
Announces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines utilizing Novavax's Matrix-MTM adjuvantThis agreement represents a...

at 02:05
Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") and Maze Therapeutics, Inc. (Head Office: South San Francisco, California, USA; Chief Executive Officer: Jason Coloma, Ph.D.;...

at 02:00
Agreement provides individuals with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, from 2025 onwardsProvides Novavax with cash and an equity investment totalling approximately $1.2 billion...

at 01:00
REGULATED INFORMATIONMay 10, 2024, 7:00am CET / 1:00am ET NYXOAH SA(Euronext Brussels: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter the "Company") Invitation to attend the annual and the extraordinary shareholders'...

at 00:16
WestGene, a biotech company dedicated to mRNA technology, announces a historic milestone with the FDA IND approval of its mRNA therapeutic cancer vaccine, WGc-043. This landmark achievement marks the world's first approval of an EB virus-related mRNA...

at 00:00
SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer (SCLC) for SNB-101 (API: SN-38), a new drug for polymer nanoparticle anticancer under clinical trial. SNB-101...



News published on and distributed by: